Raiffeisen Bank International »

Janux Therapeutics shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $717k 55k 13.03

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
Prosight Management
Vanguard Group
FMR
State Street Corporation
Vanguard Capital Management
TCG Crossover Management
Alyeska Investment Group
Wellington Management Company
Vanguard Portfolio Management
Deep Track Capital
Point72 Asset Management
Geode Capital Management

View all funds holding Janux Therapeutics